- Home
- VMAR vs APLM Comparison
VMAR vs APLM Comparison
Compare VMAR & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- APLM
- Stock Information
- Founded
- VMAR 1995
- APLM 2016
- Country
- VMAR Canada
- APLM United States
- Employees
- VMAR N/A
- APLM N/A
- Industry
- VMAR Marine Transportation
- APLM Blank Checks
- Sector
- VMAR Industrials
- APLM Finance
- Exchange
- VMAR Nasdaq
- APLM Nasdaq
- Market Cap
- VMAR 4.5M
- APLM 6.1M
- IPO Year
- VMAR 2020
- APLM N/A
- Fundamental
- Price
- VMAR $1.37
- APLM $3.93
- Analyst Decision
- VMAR
- APLM
- Analyst Count
- VMAR 0
- APLM 0
- Target Price
- VMAR N/A
- APLM N/A
- AVG Volume (30 Days)
- VMAR 1.5M
- APLM 22.4K
- Earning Date
- VMAR 07-11-2025
- APLM 09-12-2025
- Dividend Yield
- VMAR N/A
- APLM N/A
- EPS Growth
- VMAR N/A
- APLM N/A
- EPS
- VMAR N/A
- APLM N/A
- Revenue
- VMAR $1,128,568.00
- APLM $198,000.00
- Revenue This Year
- VMAR N/A
- APLM $415.15
- Revenue Next Year
- VMAR $264.29
- APLM N/A
- P/E Ratio
- VMAR N/A
- APLM N/A
- Revenue Growth
- VMAR N/A
- APLM N/A
- 52 Week Low
- VMAR $1.30
- APLM $3.66
- 52 Week High
- VMAR $286.19
- APLM $35.98
- Technical
- Relative Strength Index (RSI)
- VMAR 14.46
- APLM 27.85
- Support Level
- VMAR $1.46
- APLM $5.76
- Resistance Level
- VMAR $1.64
- APLM $6.37
- Average True Range (ATR)
- VMAR 0.25
- APLM 0.45
- MACD
- VMAR -0.04
- APLM -0.15
- Stochastic Oscillator
- VMAR 1.81
- APLM 9.38
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.